Emerging Company Profile
Orna: turning circular RNAs into therapies
Emerging Company Profile: Orna launches with $80M to develop circular RNA therapies
Orna, seeded and incubated by MPM, launches with an $80 million series A and a platform of circular RNA therapies packaged in lipid nanoparticles for delivery to desired cells and tissues.
Feb 27, 2021 | 12:30 AM GMT
Orna emerged from stealth